{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:49Z","timestamp":1791297829987,"version":"4.1.0"},"reference-count":38,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":3483,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n                  <jats:p>Current therapies for type 1 diabetes (T1D) involve insulin replacement or transplantation of insulin-secreting tissue, both of which suffer from numerous limitations and complications. Here, we show that subcutaneous transplants of embryonic brown adipose tissue (BAT) can correct T1D in streptozotocin-treated mice (both immune competent and immune deficient) with severely impaired glucose tolerance and significant loss of adipose tissue. BAT transplants result in euglycemia, normalized glucose tolerance, reduced tissue inflammation, and reversal of clinical diabetes markers such as polyuria, polydipsia, and polyphagia. These effects are independent of insulin but correlate with recovery of the animals\u2019 white adipose tissue. BAT transplants lead to significant increases in adiponectin and leptin, but with levels that are static and not responsive to glucose. Pharmacological blockade of the insulin receptor in BAT transplant mice leads to impaired glucose tolerance, similar to what is seen in nondiabetic animals, indicating that insulin receptor activity plays a role in the reversal of diabetes. One possible candidate for activating the insulin receptor is IGF-1, whose levels are also significantly elevated in BAT transplant mice. Thus, we propose that the combined action of multiple adipokines establishes a new equilibrium in the animal that allows for chronic glycemic control without insulin.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db11-0510","type":"journal-article","created":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T06:22:26Z","timestamp":1328768546000},"page":"674-682","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":261,"title":["Reversal of Type 1 Diabetes in Mice by Brown Adipose Tissue Transplant"],"prefix":"10.2337","volume":"61","author":[{"given":"Subhadra C.","family":"Gunawardana","sequence":"first","affiliation":[{"name":"Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Piston","sequence":"additional","affiliation":[{"name":"Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2012,2,13]]},"reference":[{"key":"2022031210222381300_B1","first-page":"128a","article-title":"Hormonal control of metabolism: regulation of plasma glucose","volume":"21","author":"Casey","year":"2003","journal-title":"Surgery"},{"key":"2022031210222381300_B2","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s10620-008-0585-3","article-title":"Adipose tissue: the new endocrine organ? A review article","volume":"54","author":"Wozniak","year":"2009","journal-title":"Dig Dis Sci"},{"key":"2022031210222381300_B3","doi-asserted-by":"crossref","first-page":"242S","DOI":"10.1038\/oby.2006.317","article-title":"Adipose tissue as an endocrine organ","volume":"14","author":"Ahima","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"2022031210222381300_B4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1745-7270.2007.00255.x","article-title":"Adiponectin decreases plasma glucose and improves insulin sensitivity in diabetic Swine","volume":"39","author":"Hu","year":"2007","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2022031210222381300_B5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jgm.1104","article-title":"Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection","volume":"9","author":"Fukushima","year":"2007","journal-title":"J Gene Med"},{"key":"2022031210222381300_B6","doi-asserted-by":"crossref","first-page":"14070","DOI":"10.1073\/pnas.0806993105","article-title":"Making insulin-deficient type 1 diabetic rodents thrive without insulin","volume":"105","author":"Yu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031210222381300_B7","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1073\/pnas.0909422107","article-title":"Leptin therapy in insulin-deficient type I diabetes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031210222381300_B8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1464-5491.2010.02956.x","article-title":"Temporal patterns in overweight and obesity in type 1 diabetes","volume":"27","author":"Conway","year":"2010","journal-title":"Diabet Med"},{"key":"2022031210222381300_B9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ijo.2009.75","article-title":"Adiposity and mortality in type 1 diabetes","volume":"33","author":"Conway","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"2022031210222381300_B10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","article-title":"Modern-day clinical course of type 1 diabetes mellitus after 30 years\u2019 duration: the diabetes control and complications trial\/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005)","volume":"169","author":"Nathan","year":"2009","journal-title":"Arch Intern Med"},{"key":"2022031210222381300_B11","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1152\/ajpendo.90544.2008","article-title":"Subcutaneous transplantation of embryonic pancreas for correction of type 1 diabetes","volume":"296","author":"Gunawardana","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210222381300_B12"},{"key":"2022031210222381300_B13","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1074\/jbc.M411863200","article-title":"The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species","volume":"280","author":"Lin","year":"2005","journal-title":"J Biol Chem"},{"key":"2022031210222381300_B14","author":"Yessoufou","year":"2011"},{"key":"2022031210222381300_B15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2337\/db09-1338","article-title":"Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis","volume":"59","author":"Luo","year":"2010","journal-title":"Diabetes"},{"key":"2022031210222381300_B16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1194\/jlr.M400373-JLR200","article-title":"Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation","volume":"46","author":"Fu","year":"2005","journal-title":"J Lipid Res"},{"key":"2022031210222381300_B17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"302","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"2022031210222381300_B18","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.2337\/diacare.26.12.3226","article-title":"Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians","volume":"26","author":"Snehalatha","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031210222381300_B19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2249.2010.04193.x","article-title":"Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis","volume":"161","author":"Kaas","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2022031210222381300_B20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/db10-0426","article-title":"Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice","volume":"60","author":"Lee","year":"2011","journal-title":"Diabetes"},{"key":"2022031210222381300_B21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2337\/db10-1594","article-title":"Glucagon as a critical factor in the pathology of diabetes","volume":"60","author":"Edgerton","year":"2011","journal-title":"Diabetes"},{"key":"2022031210222381300_B22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13813450600736174","article-title":"Insulin signalling in human adipose tissue","volume":"112","author":"Laviola","year":"2006","journal-title":"Arch Physiol Biochem"},{"key":"2022031210222381300_B23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbrc.2008.08.151","article-title":"A novel high-affinity peptide antagonist to the insulin receptor","volume":"376","author":"Sch\u00e4ffer","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031210222381300_B24","author":"Grossman","year":"2010"},{"key":"2022031210222381300_B25","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.2337\/db05-1275","article-title":"Recovery of islet beta-cell function in streptozotocin- induced diabetic mice: an indirect role for the spleen","volume":"55","author":"Yin","year":"2006","journal-title":"Diabetes"},{"key":"2022031210222381300_B26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1","volume":"3","author":"LeRoith","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2022031210222381300_B27","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI116109","article-title":"Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus","volume":"90","author":"Zenobi","year":"1992","journal-title":"J Clin Invest"},{"key":"2022031210222381300_B28","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2009-2502","article-title":"Effects of insulin-like growth factor (IGF)-I\/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance","volume":"95","author":"Rao","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210222381300_B29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/eje.0.1310251","article-title":"Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A","volume":"131","author":"Zenobi","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"2022031210222381300_B30","first-page":"101","article-title":"Insulin-like growth factor I and impaired glucose tolerance","volume":"62","author":"Dunger","year":"2004","journal-title":"Horm Res"},{"key":"2022031210222381300_B31","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/art.11303","article-title":"Evidence for a key role of leptin in osteoarthritis","volume":"48","author":"Dumond","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2022031210222381300_B32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/meta.2000.6745","article-title":"Serum leptin concentrations during severe protein-energy malnutrition: correlation with growth parameters and endocrine function","volume":"49","author":"Soliman","year":"2000","journal-title":"Metabolism"},{"key":"2022031210222381300_B33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00198-007-0487-9","article-title":"Leptin and the sympathetic connection of fat to bone","volume":"19","author":"Hamrick","year":"2008","journal-title":"Osteoporos Int"},{"key":"2022031210222381300_B34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nm0106-30","article-title":"RBP4, an unexpected adipokine","volume":"12","author":"Tamori","year":"2006","journal-title":"Nat Med"},{"key":"2022031210222381300_B35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000321970","article-title":"Body composition differences in normal weight, obese-overweight and anorexic adolescents: role of adipocytokines","volume":"55","author":"Ondrak","year":"2010","journal-title":"Med Sport Sci"},{"key":"2022031210222381300_B36","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1210\/jc.2007-1755","article-title":"High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus","volume":"93","author":"Choi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210222381300_B37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1172\/JCI2849","article-title":"Obesity and diabetes in TNF-alpha receptor- deficient mice","volume":"102","author":"Schreyer","year":"1998","journal-title":"J Clin Invest"},{"key":"2022031210222381300_B38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/61\/3\/674\/559818\/674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/61\/3\/674\/559818\/674.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:26:59Z","timestamp":1667406419000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/61\/3\/674\/15721\/Reversal-of-Type-1-Diabetes-in-Mice-by-Brown"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,13]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,2,13]]},"published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db11-0510","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,13]]}}}